GDC-0134
- Generic Name
- GDC-0134
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H20F4N6O2
- CAS Number
- 1637394-01-4
- Unique Ingredient Identifier
- 4N6KQ7D685
- Associated Conditions
- -
- Associated Therapies
- -
A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT02655614
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Mayo Clinic Hospital - Florida, Jacksonville, Florida, United States
🇺🇸Forbes Norris Mda/als Ctr; Research Center, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath